top of page
The Next Generation in Immuno-Oncology
OUR TECHNOLOGY
Meditope Biosciences is revolutionizing the use of monoclonal antibodies. Our proprietary SnAP technology leverages a naturally occurring space in an antibody and carves it into a binding site.
OUR TECHNOLOGY
OUR TEAM
Drawn by a passion for the SnAP technology and all the innovative potential that it represents, the Meditope Biosciences' team represents an impressive and remarkable blend of breadth and depth of experience.
TEAM
CONTACT
bottom of page